Home Tools
Log in
Cart

Search Result

Search Results for " mc-mmae "

11

Compounds

Cat No. Product Name Synonyms Targets
T18312 Mc-MMAE Maleimidocaproyl-monomethylauristatin E Microtubule Associated
Mc-MMAE (Maleimidocaproyl-monomethylauristatin E) is a drug-linker conjugate for ADC. Mc-MMAE is a maleimidocaproyl-conjugated monomethyl auristatin E, which is a potent tubulin inhibitor.
T39164 MC-betaglucuronide-MMAE-1
MC-betaglucuronide-MMAE-1 is a potent antitumor drug-linker conjugate for antibody-drug conjugates (ADCs), employing MMAE (a tubulin polymerization inhibitor) connected through the cleavable ADC linker MC-betaglucuronide...
T4232 VCMMAE mc-vc-PAB-MMAE Microtubule Associated
VCMMAE (mc-vc-PAB-MMAE) is a drug-linker conjugate for ADC with potent antitumor activity.
T81835 MC-betaglucuronide-MMAE-2
MC-betaglucuronide-MMAE-2 is an ADC (antibody-drug conjugate) agent-linker conjugate that exhibits potent antitumor activity; it consists of MMAE (a tubulin polymerization inhibitor) connected through the cleavable linke...
T77853 MC-VA-PABC-MMAE
MC-VA-PABC-MMAE is a conjugate consisting of the ADC linker peptide MC-VA-PABC and the cytotoxic agent monomethyl auristatin E (MMAE), a powerful inhibitor of tubulin polymerization [1] [2]. This compound serves as an ag...
T79206 MC-EVCit-PAB-MMAE
MC-EVCit-PAB-MMAE (Linker-Payload 11), a conjugate utilized in antibody-drug conjugates (ADCs), comprises the MC-EVCit-PAB linker attached to the powerful tubulin polymerization inhibitor MMAE [1].
T79039 GGGDTDTC-Mc-vc-PAB-MMAE
GGGDTDTC-Mc-vc-PAB-MMAE is a drug-linker conjugate for antibody-drug conjugates (ADCs), incorporating the tubulin inhibitor monomethyl auristatin E (MMAE) as the cytotoxic component [1].
T77839 Bi-Mc-VC-PAB-MMAE
Bi-Mc-VC-PAB-MMAE is an agent-linker conjugate for antibody-drug conjugates (ADCs), featuring the linker (Fmoc-Val-Cit-PAB) and the potent tubulin inhibitor (MMAE).
T78521 Mc-Alanyl-Alanyl-Asparagine-PAB-MMAE Others
Compound S6, Mc-Alanyl-Alanyl-Asparagine-PAB-MMAE, is a potent anticancer agent specifically activated by the tumor microenvironment; it demonstrates efficacy in suppressing tumor growth in mice[1].
T18321 Mc-Val-Cit-PAB-Cl Others
Mc-Val-Cit-PAB-Cl, a cleavable ADC linker, is utilized in the conjugation of MMAE and antibodies to produce compounds such as antibody-MC-vc-MMAE (e.g., anti-CD22-MC-VC-PABC-MMAE), which demonstrate cytotoxicity with IC5...
T77838 Telisotuzumab vedotin ABBV-399
Telisotuzumab vedotin (ABBV-399), an antibody-drug conjugate (ADCs), targets c-Met and comprises the cytotoxic agent Monomethyl Auristatin E (MMAE), the Telisotuzumab antibody, and a cleavable mc-val-cit-PABC linker. Thi...
TargetMol